The Technical Analyst
Select Language :
Vaccinex Inc [VCNX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Vaccinex Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Vaccinex Inc is listed at the  Exchange

1.23% $7.59

America/New_York / 28 mar 2024 @ 10:42


FUNDAMENTALS
MarketCap: 8.86 mill
EPS: -83.86
P/E: -0.0900
Earnings Date: Mar 31, 2024
SharesOutstanding: 1.167 mill
Avg Daily Volume: 0.0115 mill
RATING 2024-03-27
C+
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Strong Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0900 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.02x
Company: PE -0.0900 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.853
(-75.59%) $-5.74
Date: 2024-03-28
Expected Trading Range (DAY)

$ 6.58 - 8.61

( +/- 13.38%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-20 Evans Elizabeth E. Buy 1 341 Stock Option (Right to Buy)
2024-03-20 Smith Ernest S. Buy 1 341 Stock Option (Right to Buy)
2024-03-20 Sanchez Jill Buy 805 Stock Option (Right to Buy)
2024-03-20 Zauderer Maurice Buy 1 877 Stock Option (Right to Buy)
2024-03-14 Sanchez Jill Sell 76 Stock Option (Right to Buy)
INSIDER POWER
99.87
Last 100 transactions
Buy: 40 126 400 | Sell: 9 809 782

Forecast: 12:43 - $7.58

Live Trading Signals (every 1 min)

Forecast 1: 11:13 - $7.53
Forecast 2: 12:03 - $7.58
Forecast 3: 12:43 - $7.58
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price $7.59 (1.23% )
Volume 0.0083 mill
Avg. Vol. 0.0115 mill
% of Avg. Vol 71.76 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Vaccinex Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Vaccinex Inc

RSI

Last 10 Buy & Sell Signals For VCNX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Vaccinex Inc

VCNX

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.

Last 10 Buy Signals

Date Signal @
ZMMar 28 - 11:04$66.58
SWKSMar 28 - 11:03$108.50
UPSTMar 28 - 11:02$27.72
CTSHMar 28 - 11:02$73.53
PLUGMar 28 - 11:01$3.43
CIFRMar 28 - 11:01$5.43
NEXOUSDMar 28 - 11:001.339
ABTUSDMar 28 - 10:541.877
ZIMar 28 - 10:57$15.86
HSTMar 28 - 10:56$20.72

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.